Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SLS Venture

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 8
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.43
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Hospital
  • Medical Device
  • Pharmaceutical
Summary

The company was established in Europe in Sweden. The leading representative office of defined VC is situated in the Stockholm.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Denmark. Among the most popular fund investment industries, there are Pharmaceutical, Hospital. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Light Sciences Oncology, AdvanDx, OxThera.

The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. The top activity for fund was in 2005. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this SLS Venture performs on 8 percentage points less the average number of lead investments.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the SLS Venture, startups are often financed by LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are LD Pensions, Novo Holdings, Essex Woodlands Healthcare Partners. In the next rounds fund is usually obtained by LD Pensions, Industrifonden, Sunstone Life Science Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SLS Venture:
Typical Co-investors
SLS Venture is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SLS Venture:

Funds with similar focus

Funds from Sweden
Funds with similar focus located in Sweden:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Daocin Capital China, Hangzhou, Zhejiang
Estalea California, Santa Barbara, United States
First Green Partners Minneapolis, Minnesota, United States
Innovation Department New York, New York, United States
Latin American Media Group Brazil, São Paulo, Sao Paulo
SEIS England, London, United Kingdom
Sheridan Legacy Group Chicago, Illinois, United States
Solomon Global Holdings Columbus, Ohio, United States
The Fishman Group Israel, Tel Aviv, Tel Aviv District
Tourbillon Global Ventures New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Action Pharma

Biotechnology
Health Care
Pharmaceutical
$6M16 Jul 2010 Central Denmark Region

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$8M12 Oct 2009 Woburn, Massachusetts, United States

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$15M18 Sep 2007 Woburn, Massachusetts, United States

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$5M08 May 2006 Woburn, Massachusetts, United States

Light Sciences Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
$32M14 Dec 2005 Bellevue, Washington, United States

BioPheresis

Biotechnology
Health Care
Medical
$8M13 May 2005 Baden-Württemberg

Symphogen

Biopharma
Biotechnology
Drug Discovery
Pharmaceutical
$25M05 Nov 2004 Capital Region of Denmark

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$5M24 Nov 2003 Woburn, Massachusetts, United States

Nuevolution

Biotechnology
Health Care
Medical
$15M10 Oct 2003 Copenhagen, Capital Region of Denmark, Denmark

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SLS Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 15M
Peak activity year 2005
Lead investments 1
Follow on index 0.43
Exits 4
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Action Pharma

Biotechnology
Health Care
Pharmaceutical
$6M16 Jul 2010 Central Denmark Region

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$8M12 Oct 2009 Woburn, Massachusetts, United States

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$15M18 Sep 2007 Woburn, Massachusetts, United States

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$5M08 May 2006 Woburn, Massachusetts, United States

Light Sciences Oncology

Biotechnology
Health Care
Medical
Pharmaceutical
$32M14 Dec 2005 Bellevue, Washington, United States

BioPheresis

Biotechnology
Health Care
Medical
$8M13 May 2005 Baden-Württemberg

Symphogen

Biopharma
Biotechnology
Drug Discovery
Pharmaceutical
$25M05 Nov 2004 Capital Region of Denmark

AdvanDx

Biotechnology
Health Care
Hospital
Medical Device
$5M24 Nov 2003 Woburn, Massachusetts, United States

Nuevolution

Biotechnology
Health Care
Medical
$15M10 Oct 2003 Copenhagen, Capital Region of Denmark, Denmark
Crunchbase icon

Content report

The following text will be sent to our editors: